New GMPs Will Have Limited Impact On Listed Companies
This article was originally published in PharmAsia News
Executive Summary
With the official release of China's updated Good Manufacturing Practice standards (GMPs) expected this month, some analysts predict limited impact on listed drug companies, based on a draft version released earlier this year